著者について. JieJackLi is a medicinal chemist at Pfizer Global Research and Development in Ann Arbor, Michigan. He is coauthor of Contemporary Drug Synthesis and editor of Name Reactions in Heterocyclic Chemistry (both from Wiley).
JIEJACKLI is a medicinal chemist at Pf izer Global Research and Development in Ann Arbor, Michigan. His research interests include medicinal chemistry, heterocyclic chemistry, transition metal-catalyzed reactions, and radical chemistry .
著者について. Douglas S. Johnson, PHD, is a Research Chemist at Pfizer Global Research and Development. JieJackLi, PHD, is a Research Chemist at Pfizer Global Research and Development.
JIEJACKLI is a chemist at Bristol-Myers Squibb Company in Wallingford, Connecticut. He has authored or edited various books, including Name Reactions in Heterocyclic Chemistry, Name Reactions for Functional Group Transformations, ...
JieJackLi is a chemist at Bristol-Myers Squibb Company. He received his BS from Nanjing University and his PhD in organic chemistry at Indiana University. Dr. Li completed a postdoctoral fellowship at MIT. He is coauthor of various books , ...
著者について. JieJackLi is a Chemist at Bristol-Myers Squibb Company. He has authored or edited various books, including the first volume of Name Reactions in Heterocyclic Chemistry, Name Reactions for Functional Group Transformations, ...